Outsourced Pharma App Notes & Case Studies
-
Long-Term Container Closure Integrity Testing Of Vial-Stopper-Seal Combinations
9/3/2024
The study was designed to investigate CCI over a period of 24 months at ambient, ultra-low and cryogenic temperatures for serum-stopper samples and at ambient temperature for lyo-stopper samples.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges
2/3/2025
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
Elevating Downstream Process Development With Real-Time Data Monitoring
7/11/2025
Learn how real-time monitoring with PAT enhances process control, shortens development timelines, and supports the shift toward continuous manufacturing in biopharmaceutical production.
-
Overcoming Food Effects, Variability, Solubility For A Non-Opioid Analgesic With Lipid-Based Formulations
3/20/2026
Develop optimized lipid-based formulations to overcome solubility, stability, and food-effect challenges, enabling high-dose oral delivery and rapid progression to Phase 1 trials.
-
Selecting A Platform Filter For High Concentration mAbs
4/9/2025
Read more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.
-
Virus Retention Performance Under Diverse Processing Conditions
11/14/2025
Virus filtration is robust across a wide range of process parameters, including high protein concentration and flow decay. Discover how retention relies on size exclusion to simplify risk assessment.
-
Tackling Antimicrobial Resistance
5/14/2024
Learn how three companies collaborated to develop a new antibiotic to address the increasing development of antimicrobial resistance (AMR) that threatens the global health landscape.
-
Optimizing TFF And SPTFF For High-Concentration mAb Formulations
4/9/2025
Discover the critical role of formulation buffer composition in stabilizing monoclonal antibodies during tangential flow filtration, a process involving ultrafiltration and diafiltration under high pressure and shear forces.
-
Reducing Risk And Timelines In Cell Line Development
3/25/2025
Accelerate your biologic development by adopting faster, more reliable clone selection methods that reduce time and resources while improving the likelihood of identifying stable, high-producing cell lines.
-
Cell Retention Technology And Specialized Cell Culture Media
8/11/2025
Explore how perfusion technology is transforming upstream bioprocessing by boosting productivity, reducing costs, and enabling process intensification while overcoming cell retention challenges.